Skip to main content
. 2021 May 31;11:11350. doi: 10.1038/s41598-021-90879-z

Figure 2.

Figure 2

Changes in outcome measures in the group treated with dapagliflozin and protein-rich formula diet (P-FD) and the group treated with dapagliflozin and fat-rich formula diet (F-FD). (A) Change in HbA1c, (B) change in fasting glucose, (C) change in body weight. Data are presented as mean ± SD.